Menopausal hormone therapy use in relation to breast cancer incidence in 11 European countries.


INTRODUCTION The use of menopausal hormone therapy (MHT) has decreased in many countries in the past 10 years. This is a consequence of the initial publication of the results of the Women's Health Initiative (WHI) randomized trial of estrogen plus progestin. In various countries, further studies then analyzed the incidence of breast cancer (BC) in relation… (More)
DOI: 10.1016/j.maturitas.2015.11.010


3 Figures and Tables

Blog articles referencing this paper

Slides referencing similar topics